Stella Diagnostics Presents Study at American College of Gastroenterology
The original release is unavailable here.
Stella Diagnostics Inc. on 6ix
Earlier from Stella Diagnostics
- Stella Diagnostics and Collaborators Publish Peer-Reviewed Article Highlighting Current Limitations and Future Innovations for Barrett’s Esophagus-Related Cancer
- Stella Diagnostics Announces Completion of Corporate Name and Ticker Symbol Changes (SLDX)
- Stella Diagnostics to Present at the Benzinga Biotech Small Cap Conference
- Stella Diagnostics and the University of Kansas Medical Center Enter Into Collaborative Research Agreement
- Stella Diagnostics Announces Key Additions to its Board of Directors
Later from Stella Diagnostics
- Stella Diagnostics Named ‘Best Clinical Proteomics Solution’ of 2021 by Biotech Breakthrough Awards
- Stella Diagnostics to Present at “Next Big Thing” Session at Society of American Gastroenterologists and Endoscopic Surgeons Annual Meeting
- Stella Diagnostics Announces Data Presentation at the American Association for Cancer Research (AACR) Annual Meeting
- Stella Diagnostics Announces Leadership Changes: Dr. Joe Abdo Assumes a New Role as Chief Scientific Officer, and Director David Seaburg is Appointed Chief Executive Officer
- Stella Diagnostics and Mayo Clinic to Present Data on the Utility of the STLA101 Test for Esophageal Cancer Staging at the 2022 AGA Digestive Disease Week Conference
Follow Stella Diagnostics into a list and get an email when it puts out news.
Follow Stella Diagnostics